Wednesday, July 8, 2026

pharma · Solid Tumors · Primary Dysmenorrhea

Topiloric/Uriadec

Topiloric/Uriadec clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

SOUTH SAN FRANCISCO, CA, JP HQ
2 Employees
PMDA registrant Type
Company details
Status
Public
HQ
SOUTH SAN FRANCISCO, CA, JP
Employees
2
Programs
12
Drugs
7
Patents
52
Intelligence · Clinical Programs

Topiloric/Uriadec projects

1 ClinicalTrials.gov programs sponsored by Topiloric/Uriadec.

Topiloric/Uriadec has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. AgnoMed

    Topiloric/Uriadec

    Primary Dysmenorrhea

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Topiloric/Uriadec have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.